Gain Therapeutics Inc (GANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,161 | -20,411 | -22,268 | -17,591 | -13,891 |
| Depreciation Amortization | 94 | 84 | 84 | 64 | 16 |
| Accounts receivable | N/A | N/A | N/A | N/A | 8 |
| Accounts payable and accrued liabilities | -469 | 275 | -694 | 1,067 | -521 |
| Other Working Capital | -1,007 | -1,080 | 442 | 1,515 | -330 |
| Other Operating Activity | 3,077 | 2,259 | 3,570 | 253 | 2,352 |
| Operating Cash Flow | $-18,465 | $-18,874 | $-18,866 | $-14,692 | $-12,366 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -23 | -15 | -119 | -94 |
| Purchase Of Investment | N/A | N/A | -1,956 | -17,735 | 0 |
| Sale Of Investment | N/A | 5,000 | 12,194 | 3,080 | N/A |
| Investing Cash Flow | $N/A | $4,978 | $10,223 | $-14,775 | $-94 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -97 | -91 | -89 | -79 | -22 |
| Common Stock Issued | 28,940 | 13,384 | 12,730 | N/A | 42,642 |
| Other Financing Activity | -395 | -281 | 0 | 0 | -853 |
| Financing Cash Flow | $28,448 | $13,012 | $12,641 | $-79 | $41,767 |
| Exchange Rate Effect | 474 | -527 | 488 | -24 | 101 |
| Beginning Cash Position | 10,418 | 11,829 | 7,342 | 36,912 | 7,504 |
| End Cash Position | 20,874 | 10,418 | 11,829 | 7,342 | 36,912 |
| Net Cash Flow | $10,456 | $-1,411 | $4,487 | $-29,570 | $29,408 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,465 | -18,874 | -18,866 | -14,692 | -12,366 |
| Capital Expenditure | N/A | -23 | -15 | -119 | -94 |
| Free Cash Flow | -18,465 | -18,896 | -18,881 | -14,811 | -12,460 |